Literature DB >> 11267681

Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung.

D R Kim1, S Sharmin, M Inoue, H Kido.   

Abstract

Two cDNAs encoding novel mosaic proteins with a serine protease domain and potential regulatory modules, consisting of a protein kinase substrate and a low-density lipoprotein receptor, were cloned from a human lung cDNA library by PCR. One with a transmembrane domain (MSPL) and the other without one (MSPS) comprise 581 and 537 amino acids, respectively. Except for the C-terminal ends, the two isoforms had an identical serine protease domain exhibiting 42, 39 and 43% identity with those of plasma kallikrein, hepsin and transmembrane protease serine 2, respectively. Both genes were predominantly expressed in human lung, placenta, pancreas and prostate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267681     DOI: 10.1016/s0167-4781(01)00184-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.

Authors:  Yuushi Okumura; Masaki Hayama; Etsuhisa Takahashi; Mieko Fujiuchi; Aki Shimabukuro; Mihiro Yano; Hiroshi Kido
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

2.  Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Authors:  Andrew S Murray; Fausto A Varela; Thomas E Hyland; Andrew J Schoenbeck; Jordan M White; Lauren M Tanabe; Sokol V Todi; Karin List
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

3.  Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.

Authors:  Yuushi Okumura; Etsuhisa Takahashi; Mihiro Yano; Masanobu Ohuchi; Tomo Daidoji; Takaaki Nakaya; Eva Böttcher; Wolfgang Garten; Hans-Dieter Klenk; Hiroshi Kido
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Boye Schnack Nielsen; Thomas H Bugge
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Authors:  Roman Szabo; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

6.  Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues.

Authors:  John D Hooper; Luisa Campagnolo; Goodarz Goodarzi; Tony N Truong; Heidi Stuhlmann; James P Quigley
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 7.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.

Authors:  Andrew J Ramsay; John D Hooper; Alicia R Folgueras; Gloria Velasco; Carlos López-Otín
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

8.  TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition.

Authors:  Daniel H Madsen; Roman Szabo; Alfredo A Molinolo; Thomas H Bugge
Journal:  Biochem J       Date:  2014-08-01       Impact factor: 3.857

Review 9.  Membrane associated proteases and their inhibitors in tumour angiogenesis.

Authors:  A Noel; C Maillard; N Rocks; M Jost; V Chabottaux; N E Sounni; E Maquoi; D Cataldo; J M Foidart
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

Review 10.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.